14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Aug 30, 2023 Buy 8 500 Johnson Laura L. Options (Right to Buy)
Aug 30, 2023 Buy 8 500 Favorito Tamara A Options (Right to Buy)
Aug 30, 2023 Buy 23 142 Hoffman Robert E. Options (Right to Buy)
Aug 30, 2023 Buy 8 500 Toth Robert Joseph Jr Options (Right to Buy)
Aug 30, 2023 Buy 10 175 Brown Dennis M Options (Right to Buy)
Jun 01, 2023 Buy 59 800 Hoffman Robert E. Common Stock, par value $0.001 per share
Jan 05, 2023 Buy 363 Brown Dennis M Common Stock, par value $0.001 per share
Aug 01, 2022 Buy 240 087 Praill Anthony Scott Common Stock
Aug 01, 2022 Buy 240 087 Brown Dennis M Common Stock
Aug 01, 2022 Buy 1 200 634 Hoffman Robert E. Option (right to buy)
Jul 01, 2022 Buy 100 000 Johnson Laura L. Options (Right to Buy)
Jul 01, 2022 Buy 100 000 Toth Robert Joseph Jr Options (Right to Buy)
Jul 01, 2022 Buy 100 000 Toth Robert Joseph Jr Options (Right to Buy)
Jul 01, 2022 Buy 100 000 Seymour Tamara A Options (Right to Buy)
Feb 15, 2022 Buy 55 000 Hoffman Robert E. Common Stock
Dec 08, 2021 Buy 28 700 Praill Anthony Scott Common Stock
Dec 07, 2021 Buy 38 109 Zarrabian Saiid Common Stock
Dec 06, 2021 Buy 11 891 Zarrabian Saiid Common Stock
Nov 22, 2021 Buy 3 000 Johnson Laura L. Common Stock
Nov 08, 2021 Buy 3 519 170 Hoffman Robert Options (Right to Buy)
Sep 22, 2021 Buy 100 000 Murphy Keith Options (Right to Buy)
Sep 22, 2021 Buy 100 000 Toth Robert Joseph Jr Options (Right to Buy)
Sep 22, 2021 Buy 35 000 Seymour Tamara A Options (Right to Buy)
Sep 22, 2021 Buy 100 000 Hoffman Robert Options (Right to Buy)
Sep 22, 2021 Buy 100 000 Johnson Laura L. Options (Right to Buy)
Apr 29, 2021 Buy 75 000 Seymour Tamara A Options (Right to Grant)
Apr 29, 2021 Buy 0 Seymour Tamara A
Apr 29, 2021 Buy 750 Brown Dennis M Common Stock
Apr 29, 2021 Buy 6 Brown Dennis M Common Stock
Apr 29, 2021 Sell 3 000 Brown Dennis M Series B Convertible Preferred Stock
Apr 29, 2021 Buy 938 Praill Anthony Scott Common Stock
Apr 29, 2021 Buy 8 Praill Anthony Scott Common Stock
Apr 29, 2021 Sell 3 750 Praill Anthony Scott Series B Convertible Preferred Stock
Apr 29, 2021 Buy 325 Toth Robert Joseph Jr Common Stock
Apr 29, 2021 Buy 3 Toth Robert Joseph Jr Common Stock
Apr 29, 2021 Sell 1 300 Toth Robert Joseph Jr Series B Convertible Preferred Stock
Mar 31, 2021 Buy 8 Toth Robert Joseph Jr Common Stock
Mar 31, 2021 Buy 17 Brown Dennis M Common Stock
Mar 31, 2021 Buy 22 Praill Anthony Scott Common Stock
Dec 31, 2020 Buy 17 Brown Dennis M Common Stock
Dec 31, 2020 Buy 8 Toth Robert Joseph Jr Common Stock
Dec 31, 2020 Buy 22 Praill Anthony Scott Common Stock
Sep 30, 2020 Buy 8 Toth Robert Joseph Jr Common Stock
Sep 30, 2020 Buy 22 Praill Anthony Scott Common Stock
Sep 30, 2020 Buy 17 Brown Dennis M Common Stock
Sep 22, 2020 Buy 60 000 Brown Dennis M Options (Right to Buy)
Sep 15, 2020 Buy 606 557 Praill Anthony Scott Options (Right to Buy)
Sep 15, 2020 Buy 506 647 Liatos John Options (Right to Buy)
Sep 15, 2020 Buy 87 437 Brown Dennis M Options (Right to Buy)
Sep 15, 2020 Buy 2 715 004 Zarrabian Saiid Options (Right to Buy)
Sep 15, 2020 Buy 120 000 Hoffman Robert Options (Right to Buy)
Sep 15, 2020 Buy 120 000 Toth Robert Joseph Jr Options (Right to Buy)
Sep 15, 2020 Buy 120 000 Murphy Keith Options (Right to Buy)
Sep 15, 2020 Buy 120 000 Johnson Laura L. Options (Right to Buy)
Aug 19, 2020 Buy 196 750 Liatos John Common Stock
Aug 19, 2020 Buy 181 010 Murphy Keith Common Stock
Aug 19, 2020 Buy 0 Murphy Keith
Aug 19, 2020 Buy 0 Liatos John
Jun 30, 2020 Buy 22 Praill Anthony Scott Common Stock
Jun 30, 2020 Sell 8 Cranston Lynda Sarah Common Stock
Jun 30, 2020 Buy 29 Bell John K Common Stock
Jun 30, 2020 Buy 8 Toth Robert Joseph Jr Common Stock
Jun 30, 2020 Buy 17 Brown Dennis M Common Stock
Jun 26, 2020 Buy 0 Johnson Laura L.
Jun 26, 2020 Buy 57 170 Praill Anthony Scott Option (Right to Buy)
Jun 26, 2020 Buy 39 567 Cranston Lynda Sarah Option (Right to Buy)
Jun 26, 2020 Buy 39 567 Bell John K Options (Right to Buy)
Jun 26, 2020 Buy 39 567 Toth Robert Joseph Jr Option (Right to Buy)
Jun 26, 2020 Buy 39 567 Hoffman Robert Options (Right to Buy)
Jun 26, 2020 Buy 39 567 Ferrara Napoleone Options (Right to Buy)
Jun 26, 2020 Buy 241 438 Zarrabian Saiid Options (Right to Buy)
Jun 26, 2020 Buy 250 000 Brown Dennis M Options (Right to Buy)
Jun 26, 2020 Buy 52 756 Brown Dennis M Options (Right to Buy)
Mar 31, 2020 Buy 22 Praill Anthony Scott Common Stock
Mar 31, 2020 Buy 8 Toth Robert Joseph Jr Common Stock
Mar 31, 2020 Sell 8 Cranston Lynda Sarah Common Stock
Mar 31, 2020 Buy 29 Bell John K Common Stock
Mar 31, 2020 Buy 17 Brown Dennis M Common Stock
Dec 31, 2019 Buy 17 Brown Dennis M Common Stock
Dec 31, 2019 Buy 22 Praill Anthony Scott Common Stock
Dec 31, 2019 Buy 8 Cranston Lynda Sarah Common Stock
Dec 31, 2019 Buy 8 Toth Robert Joseph Jr Common Stock
Dec 31, 2019 Buy 29 Bell John K Common Stock
Dec 27, 2019 Sell 7 500 Brown Dennis M Common Stock
Nov 12, 2019 Buy 250 000 Brown Dennis M Options (Right to Buy)
Nov 12, 2019 Buy 250 000 Brown Dennis M Options (Right to Buy)
Sep 30, 2019 Buy 8 Toth Robert Joseph Jr Common Stock
Sep 30, 2019 Buy 8 Cranston Lynda Sarah Common Stock
Sep 30, 2019 Buy 29 Bell John K Common Stock
Sep 30, 2019 Buy 22 Praill Anthony Scott Common Stock
Sep 30, 2019 Buy 17 Brown Dennis M Common Stock
Sep 13, 2019 Buy 35 000 Bell John K Common Stock
Sep 13, 2019 Buy 35 000 Bell John K Common Stock
Sep 05, 2019 Buy 39 567 Ferrara Napoleone Options (Right to Buy)
Sep 05, 2019 Buy 35 433 Ferrara Napoleone Options (Right to Buy)
Sep 05, 2019 Buy 39 567 Bell John K Options (Right to Buy)
Sep 05, 2019 Buy 35 433 Bell John K Options (Right to Buy)
Sep 05, 2019 Buy 39 567 Hoffman Robert Options (Right to Buy)
Sep 05, 2019 Buy 35 433 Hoffman Robert Options (Right to Buy)
Sep 05, 2019 Buy 52 756 Brown Dennis M Options (Right to Buy)
INSIDER POWER
66.776
Last 100 transactions
Buy: 12 848 509 | Sell: 15 566 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 66.776.

In total, the insiders bought 12 848 509 and sold 15 566 KTRA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Kintara Therapeutics Inc.

Kintara Therapeutics. Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri... KTRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT